Preisler H - Search Results

1

Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia.

Raza A, Preisler H, Lampkin B, Lykins J, Kukla C, Gartside P, Sheikh Y, Yousuf N, White M, Barcos M, et al. Raza A, et al. Among authors: preisler h. Am J Hematol. 1993 Feb;42(2):147-57. doi: 10.1002/ajh.2830420202. Am J Hematol. 1993. PMID: 8438874

2

Biological significance of cell cycle kinetics in 128 standard risk newly diagnosed patients with acute myelocytic leukemia.

Raza A, Preisler H, Lampkin B, Yousuf N, Tucker C, Peters N, White M, Kukla C, Gartside P, Siegrist C, et al. Raza A, et al. Among authors: preisler h. Br J Haematol. 1991 Sep;79(1):33-9. doi: 10.1111/j.1365-2141.1991.tb08003.x. Br J Haematol. 1991. PMID: 1911386

3

Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study.

Raza A, Preisler HD, Day R, Yasin Z, White M, Lykins J, Kukla C, Barcos M, Bennett J, Browman G, et al. Raza A, et al. Among authors: preisler hd. Blood. 1990 Dec 1;76(11):2191-7. Blood. 1990. PMID: 2257293 Free article.

4

Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986.

Baer MR, Barcos M, Farrell H, Raza A, Preisler HD. Baer MR, et al. Among authors: preisler hd. Cancer. 1989 Jun 1;63(11):2192-200. doi: 10.1002/1097-0142(19890601)63:11<2192::aid-cncr2820631122>3.0.co;2-r. Cancer. 1989. PMID: 2785843

5

Progress toward predictive models for the outcome of treatment for acute nonlymphocytic leukemia.

Preisler HD, Raza A. Preisler HD, et al. Oncology (Williston Park). 1987 May;1(3):49-59, 62. Oncology (Williston Park). 1987. PMID: 3079480 Clinical Trial.

6

Biological characteristics of newly diagnosed poor prognosis acute myelogenous leukemia.

Raza A, Preisler HD, Li YQ, Larson RA, Goldberg J, Browman G, Bennett J, Grunwald H, Vogler R, Kukla C. Raza A, et al. Among authors: preisler hd. Am J Hematol. 1993 Apr;42(4):359-66. doi: 10.1002/ajh.2830420406. Am J Hematol. 1993. PMID: 8493986

7

Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.

Raza A, Gezer S, Anderson J, Lykins J, Bennett J, Browman G, Goldberg J, Larson R, Vogler R, Preisler HD. Raza A, et al. Among authors: preisler hd. Exp Hematol. 1992 Nov;20(10):1194-200. Exp Hematol. 1992. PMID: 1426099 Clinical Trial.

8

Contribution of in vivo proliferation/differentiation studies toward the development of a combined functional and morphologic system of classification of neoplastic diseases.

Raza A, Yousuf N, Bokhari SA, Mehdi A, Masterson M, Lampkin B, Yanik G, Mazewski C, Khan S, Preisler H. Raza A, et al. Among authors: preisler h. Cancer. 1992 Mar 15;69(6 Suppl):1557-66. doi: 10.1002/1097-0142(19920315)69:6+<1557::aid-cncr2820691309>3.0.co;2-5. Cancer. 1992. PMID: 1540895 Review.

9

Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup study.

Goldberg J, Gryn J, Raza A, Bennett J, Browman G, Bryant J, Grunwald H, Larson R, Vogler R, Preisler H. Goldberg J, et al. Among authors: preisler h. Am J Hematol. 1993 Aug;43(4):286-90. doi: 10.1002/ajh.2830430411. Am J Hematol. 1993. PMID: 7690519 Clinical Trial.

10

Detection of BrdU in the regenerating bone marrow cells of a patient with AML.

Raza A, Gezer S, Mehdi I, Preisler HD. Raza A, et al. Among authors: preisler hd. Leuk Res. 1989;13(12):1055-9. doi: 10.1016/0145-2126(89)90150-1. Leuk Res. 1989. PMID: 2615464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters